$SYF
Synchrony Financial

2023 Q2 Form 10-Q Financial Statement

#000160171223000125 Filed on April 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $113.0M $111.0M
YoY Change 6.6% 3.74%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $901.0M $735.0M
YoY Change 231.25% 215.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $742.0M $790.0M
YoY Change -30.39% -35.93%
Income Tax $173.0M $189.0M
% Of Pretax Income 23.32% 23.92%
Net Earnings $559.0M $601.0M
YoY Change -30.47% -35.52%
Net Earnings / Revenue
Basic Earnings Per Share $1.32 $1.36
Diluted Earnings Per Share $1.32 $1.35
COMMON SHARES
Basic Shares Outstanding 428.6M shares 437.0M shares
Diluted Shares Outstanding 424.2M shares 437.2M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $12.71B $15.30B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $1.105B $1.105B
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $108.7B $107.9B
YoY Change 14.18% 13.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $5.321B $5.301B
YoY Change 7.69% 7.88%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.321B $5.301B
YoY Change 7.69% 7.88%
LONG-TERM LIABILITIES
Long-Term Debt $14.23B $14.93B
YoY Change 17.06% 11.78%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $14.23B $14.93B
YoY Change 17.06% 11.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.321B $5.301B
Total Long-Term Liabilities $14.23B $14.93B
Total Liabilities $95.32B $94.66B
YoY Change 16.51% 15.65%
SHAREHOLDERS EQUITY
Retained Earnings $17.83B $17.37B
YoY Change 13.71% 15.77%
Common Stock $1.000M $1.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $14.81B $14.51B
YoY Change 18.18% 22.56%
Treasury Stock Shares
Shareholders Equity $13.38B $13.19B
YoY Change
Total Liabilities & Shareholders Equity $108.7B $107.9B
YoY Change 14.18% 13.21%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $559.0M $601.0M
YoY Change -30.47% -35.52%
Depreciation, Depletion And Amortization $113.0M $111.0M
YoY Change 6.6% 3.74%
Cash From Operating Activities $1.908B $1.886B
YoY Change 5.01% 35.1%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions $0.00
YoY Change
Other Investing Activities -$5.189B $141.0M
YoY Change 393.25% 20.51%
Cash From Investing Activities -$5.189B $692.0M
YoY Change 393.25% -61.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 216.0M $2.912B
YoY Change -124.03% -398.36%
NET CHANGE
Cash From Operating Activities 1.908B $1.886B
Cash From Investing Activities -5.189B $692.0M
Cash From Financing Activities 216.0M $2.912B
Net Change In Cash -3.065B $5.490B
YoY Change 2187.31% 145.31%
FREE CASH FLOW
Cash From Operating Activities $1.908B $1.886B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001601712
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Restricted Cash Equivalents Asset Statement Of Financial Position Extensible List
RestrictedCashEquivalentsAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4 us-gaap Restricted Cash Equivalents Asset Statement Of Financial Position Extensible List
RestrictedCashEquivalentsAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36560
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SYNCHRONY FINANCIAL
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0483352
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
777 Long Ridge Road
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Stamford,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06902
CY2023Q1 dei City Area Code
CityAreaCode
203
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
585-2400
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
428570576 shares
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4616000000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4008000000 usd
CY2023Q1 syf Interestand Dividend Income Cashand Securities Operating
InterestandDividendIncomeCashandSecuritiesOperating
170000000 usd
CY2022Q1 syf Interestand Dividend Income Cashand Securities Operating
InterestandDividendIncomeCashandSecuritiesOperating
14000000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
4786000000 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
4022000000 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
557000000 usd
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
127000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
101000000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
73000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
735000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
233000000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4051000000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3789000000 usd
CY2023Q1 syf Retailer Share Arrangements
RetailerShareArrangements
917000000 usd
CY2022Q1 syf Retailer Share Arrangements
RetailerShareArrangements
1104000000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1290000000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
521000000 usd
CY2023Q1 syf Interest Income Expenseafter Retailer Share Arrangementsand Provisionfor Loan Loss
InterestIncomeExpenseafterRetailerShareArrangementsandProvisionforLoanLoss
1844000000 usd
CY2022Q1 syf Interest Income Expenseafter Retailer Share Arrangementsand Provisionfor Loan Loss
InterestIncomeExpenseafterRetailerShareArrangementsandProvisionforLoanLoss
2164000000 usd
CY2023Q1 syf Noninterest Income Interchange Revenue
NoninterestIncomeInterchangeRevenue
232000000 usd
CY2022Q1 syf Noninterest Income Interchange Revenue
NoninterestIncomeInterchangeRevenue
230000000 usd
CY2023Q1 syf Noninterest Income Debt Cancellation Fees
NoninterestIncomeDebtCancellationFees
115000000 usd
CY2022Q1 syf Noninterest Income Debt Cancellation Fees
NoninterestIncomeDebtCancellationFees
89000000 usd
CY2023Q1 syf Noninterest Expense Loyalty Programs
NoninterestExpenseLoyaltyPrograms
298000000 usd
CY2022Q1 syf Noninterest Expense Loyalty Programs
NoninterestExpenseLoyaltyPrograms
258000000 usd
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
16000000 usd
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
47000000 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
65000000 usd
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
108000000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
451000000 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
402000000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
186000000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
210000000 usd
CY2023Q1 syf Marketingand Business Development Expense
MarketingandBusinessDevelopmentExpense
131000000 usd
CY2022Q1 syf Marketingand Business Development Expense
MarketingandBusinessDevelopmentExpense
116000000 usd
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
166000000 usd
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
145000000 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
185000000 usd
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
166000000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
1119000000 usd
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
1039000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
790000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1233000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
189000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
601000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
932000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
590000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
922000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
601000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
932000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
24000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-50000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
23000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-52000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
624000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
880000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15303000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10294000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4008000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4879000000 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
91129000000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
92470000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9517000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9527000000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
81612000000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
82943000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1105000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1105000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1297000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1287000000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
4528000000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
4056000000 usd
CY2023Q1 us-gaap Assets
Assets
107853000000 usd
CY2022Q4 us-gaap Assets
Assets
104564000000 usd
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
74008000000 usd
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
71336000000 usd
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
417000000 usd
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
399000000 usd
CY2023Q1 us-gaap Deposits
Deposits
74425000000 usd
CY2022Q4 us-gaap Deposits
Deposits
71735000000 usd
CY2023Q1 us-gaap Senior Notes
SeniorNotes
8706000000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
7964000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
14934000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
14191000000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5301000000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5765000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
94660000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
91691000000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
750000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
750000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
750000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
750000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
750000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
750000 shares
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
750000000 usd
CY2023Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
750000000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
734000000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
734000000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
833984684 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
833984684 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
428447828 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
438216755 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9705000000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9718000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17369000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16716000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-69000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-93000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-39000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-38000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-6000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-6000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
405536856 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
395767929 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
14514000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
14171000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13193000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12873000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
107853000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104564000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13655000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
932000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-52000000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
968000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-25000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
14.06
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
114000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
13418000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12873000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
601000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
23000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
404000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-11000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
14.06
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
11000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
100000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13193000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
601000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
932000000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1290000000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
521000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-88000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
49000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
107000000 usd
CY2023Q1 syf Increase Decreasein Interestand Fee Receivable
IncreaseDecreaseinInterestandFeeReceivable
34000000 usd
CY2022Q1 syf Increase Decreasein Interestand Fee Receivable
IncreaseDecreaseinInterestandFeeReceivable
-65000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-19000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-177000000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-413000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-164000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-147000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1886000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1396000000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1458000000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1998000000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
391000000 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1478000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
234000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-1415000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
141000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
117000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
692000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1818000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
250000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
250000000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1150000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
740000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10000000 usd
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
2720000000 usd
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
1302000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
404000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
968000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
100000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
114000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-33000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-36000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2912000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-976000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5490000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2238000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10430000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8686000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15303000000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10541000000 usd
CY2023Q1 syf Restricted Cash And Equivalents Included In Other Assets
RestrictedCashAndEquivalentsIncludedInOtherAssets
617000000 usd
CY2022Q1 syf Restricted Cash And Equivalents Included In Other Assets
RestrictedCashAndEquivalentsIncludedInOtherAssets
383000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15920000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10924000000 usd
CY2023Q1 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interim Period Presentation</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes thereto are unaudited. These statements include all adjustments (consisting of normal recurring accruals) that we considered necessary to present a fair statement of our results of operations, financial position and cash flows. The results reported in these condensed consolidated financial statements should not be considered as necessarily indicative of results that may be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with our 2022 annual consolidated financial statements and the related notes in our Annual Report on Form 10-K for the year ended December 31, 2022 (our "2022 Form 10-K").</span></div>
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4099000000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
91000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4008000000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5001000000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
122000000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4879000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1512000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1951000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
85000000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
3590000000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
62000000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1092000000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
60000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
3253000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
3221000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Maturity Rolling Within One Year Weighted Average Yield
DebtSecuritiesAvailableForSaleMaturityRollingWithinOneYearWeightedAverageYield
0.028
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
412000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
394000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Maturity Rolling After One Through Five Years Weighted Average Yield
DebtSecuritiesAvailableForSaleMaturityRollingAfterOneThroughFiveYearsWeightedAverageYield
0.020
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
224000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
208000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Maturity Rolling After Five Through Ten Years Weighted Average Yield
DebtSecuritiesAvailableForSaleMaturityRollingAfterFiveThroughTenYearsWeightedAverageYield
0.018
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
210000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
185000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Maturity Rolling After10 Years Weighted Average Yield
DebtSecuritiesAvailableForSaleMaturityRollingAfter10YearsWeightedAverageYield
0.018
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
91129000000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
92470000000 usd
CY2023Q1 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
218000000 usd
CY2022Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
237000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9527000000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1290000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1237000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
231000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9517000000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8688000000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
521000000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
752000000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
194000000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8651000000 usd
CY2023Q1 syf Financing Receivable Allowance For Credit Loss Reasonable And Supportable Forecast Period
FinancingReceivableAllowanceForCreditLossReasonableAndSupportableForecastPeriod
P12M
CY2023Q1 syf Financing Receivable Allowance For Credit Loss Reversion Period
FinancingReceivableAllowanceForCreditLossReversionPeriod
P6M
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9500000000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1690000000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
15000000 usd
CY2023Q1 us-gaap Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
0
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
1548000000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
14000000 usd
CY2022Q4 us-gaap Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
0
CY2023Q1 syf Loansand Leases Receivable Maximum Maturity Periodfor Loansin Permanent Modification Program
LoansandLeasesReceivableMaximumMaturityPeriodforLoansinPermanentModificationProgram
P60M
CY2023Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
517000000 usd
CY2023Q1 syf Financing Receivable Modification To Total Financing Receivables Percent
FinancingReceivableModificationToTotalFinancingReceivablesPercent
0.006
CY2023Q1 syf Financing Receivable Modified Weighted Average Interest Rate Decrease From Modification
FinancingReceivableModifiedWeightedAverageInterestRateDecreaseFromModification
0.97
CY2023Q1 syf Financing Receivable Modified Amount Of Unpaid Balance Forgiven Short Term
FinancingReceivableModifiedAmountOfUnpaidBalanceForgivenShortTerm
11000000 usd
CY2023Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
2000 contract
CY2023Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
7000000 usd
CY2023Q1 syf Financing Receivable Modification Success Rate Short Term
FinancingReceivableModificationSuccessRateShortTerm
0.14
CY2022Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
224000000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1359000000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
602000000 usd
CY2022Q4 syf Impaired Financing Receivable Netof Related Allowance
ImpairedFinancingReceivableNetofRelatedAllowance
757000000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
1210000000 usd
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
9000000 usd
CY2022Q1 syf Impaired Financing Receivablewith Related Allowance Interest Income Under Original Terms
ImpairedFinancingReceivablewithRelatedAllowanceInterestIncomeUnderOriginalTerms
77000000 usd
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
1186000000 usd
CY2022Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
18000 contract
CY2023Q1 syf Other Investments In Non Consolidated Vi Es
OtherInvestmentsInNonConsolidatedVIEs
238000000 usd
CY2022Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
42000000 usd
CY2023Q1 syf Financing Receivable Credit Quality Indicators Percentage Of Loan Receivables With No Vantage Score
FinancingReceivableCreditQualityIndicatorsPercentageOfLoanReceivablesWithNoVantageScore
0.003
CY2022Q4 syf Financing Receivable Credit Quality Indicators Percentage Of Loan Receivables With No Vantage Score
FinancingReceivableCreditQualityIndicatorsPercentageOfLoanReceivablesWithNoVantageScore
0.004
CY2022Q1 syf Financing Receivable Credit Quality Indicators Percentage Of Loan Receivables With No Vantage Score
FinancingReceivableCreditQualityIndicatorsPercentageOfLoanReceivablesWithNoVantageScore
0.004
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4616000000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4008000000 usd
CY2023Q1 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
667000000 usd
CY2022Q4 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
557000000 usd
CY2022Q4 syf Other Investments In Non Consolidated Vi Es
OtherInvestmentsInNonConsolidatedVIEs
230000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3553000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2256000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1297000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3446000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2159000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1287000000 usd
CY2023Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
108000000 usd
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
74008000000 usd
CY2023Q1 syf Average Rate Domestic Deposits
AverageRateDomesticDeposits
0.031
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
71336000000 usd
CY2022Q4 syf Average Rate Domestic Deposits
AverageRateDomesticDeposits
0.015
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
417000000 usd
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
399000000 usd
CY2023Q1 us-gaap Deposits
Deposits
74425000000 usd
CY2022Q4 us-gaap Deposits
Deposits
71735000000 usd
CY2023Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
8100000000 usd
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
7200000000 usd
CY2023Q1 us-gaap Time Deposit Maturities Remainder Of Fiscal Year
TimeDepositMaturitiesRemainderOfFiscalYear
13153000000 usd
CY2023Q1 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
19966000000 usd
CY2023Q1 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
2517000000 usd
CY2023Q1 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
948000000 usd
CY2023Q1 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
2494000000 usd
CY2023Q1 syf Time Deposit Maturities After Year Four
TimeDepositMaturitiesAfterYearFour
708000000 usd
CY2023Q1 us-gaap Demand Deposit Accounts
DemandDepositAccounts
29300000000 usd
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
27800000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
14934000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
14191000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1457000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3650000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5375000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
750000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1600000000 usd
CY2023Q1 syf Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
2150000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
250000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
15303000000 usd
CY2023Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
617000000 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
93265000000 usd
CY2023Q1 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
73872000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10294000000 usd
CY2022Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
136000000 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
94339000000 usd
CY2022Q4 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
70685000000 usd
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
242000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0 usd
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
7000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
0 usd
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
2000000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
245000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
188000000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
8000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
601000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
932000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
11000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
10000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
590000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
922000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
434400000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
515300000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2800000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
437200000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
519500000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.35
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
273000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
267000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
183000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
177000000 usd
CY2023Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
72000000 usd
CY2023Q1 syf Decreasein Unrecognized Tax Benefits That Would Impact Effective Tax Rate
DecreaseinUnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
24000000 usd

Files In Submission

Name View Source Status
0001601712-23-000125-index-headers.html Edgar Link pending
0001601712-23-000125-index.html Edgar Link pending
0001601712-23-000125.txt Edgar Link pending
0001601712-23-000125-xbrl.zip Edgar Link pending
ex-31a3312023.htm Edgar Link pending
ex-31b3312023.htm Edgar Link pending
ex-323312023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
syf-20230331.htm Edgar Link pending
syf-20230331.xsd Edgar Link pending
syf-20230331_g1.jpg Edgar Link pending
syf-20230331_g2.jpg Edgar Link pending
syf-20230331_cal.xml Edgar Link unprocessable
syf-20230331_lab.xml Edgar Link unprocessable
syf-20230331_def.xml Edgar Link unprocessable
syf-20230331_pre.xml Edgar Link unprocessable
syf-20230331_htm.xml Edgar Link completed